世界の商用生産用医薬品原薬市場は。2021 年に 795 億ドルと評価されました。市場価値は、2027 年までに 1,191 億ドルに達すると予想されます。商用生産用 API (受託製造) は、より広い医薬品バリュー チェーン内に位置し、製品の臨床試験と商用製品の両方の医薬品原薬 (API) の開発と製造に関連するすべての活動を網羅しています。
化合物を製造するために必要な専門知識と設備によって、特に小規模な製薬会社やバイオテクノロジー企業は専門機関との共同事業に対する意欲が高まっています。さらに、製薬会社は研究開発やマーケティングなどのコア機能に注力するようになり、プロセスの製造側は専門の事業者に任せています。したがって、商用生産用API市場の成長を促している要因は、マージンを改善し、潜在的に市場投入までの時間を短縮するための製薬会社のアウトソーシングの増加です。2022年から2027年までの予測期間中、市場は約7％のCAGR が見込まれます。
目次
1. Executive Summary
2. Introduction
2.1 Active Pharmaceutical Ingredients (API): An Overview
2.1.1 Introduction to CDMOs and API
2.1.2 Pharma Value Chain
2.2 Merchant API: An Overview
2.2.1 Introduction to Merchant API
2.2.2 Advantages and Disadvantages of Merchant API
2.3 Merchant API Segmentation: An Analysis
2.3.1 Merchant API Segmentation
3. Global Market Analysis
3.1 Global Merchant API Market: An Analysis
3.1.1 Global Merchant API Market: An Overview
3.1.2 Global Merchant API Market by Value
3.1.3 Global Merchant API Market by Molecular Type (Small Molecules and Large Molecules)
3.1.4 Global Merchant API Market by Segment (CDMO and API Solutions)
3.1.5 Global Merchant API Market by Type (nnovative API and Generic API)
3.1.6 Global Merchant API Market by Type of Synthesis (Synthetic and Biotech)
3.1.7 Global Merchant API Market by Region (North America, Asia Pacific, Europe, and Rest of the World)
3.2 Global Merchant API Market: Molecular Type Analysis
3.2.1 Global Merchant API Market by Molecular Type: An Overview
3.2.2 Global Small Molecules Merchant API Market by Value
3.2.3 Global Large Molecules Merchant API Market by Value
3.3 Global Merchant API Market: Segment Analysis
3.3.1 Global Merchant API Market by Segment: An Overview
3.3.2 Global Merchant API CDMO Market by Value
3.3.3 Global Merchant API CDMO Market by Molecular Type (Small Molecules and Large Molecules)
3.3.4 Global Merchant API CDMO Molecular Type Market by Value
3.3.5 Global Merchant API CDMO Market by End-User (Peptides, Oligos, and Others)
3.3.6 Global Merchant API CDMO End-User Market by Value
3.3.7 Global Merchant API Solutions Market by Value
3.4 Global Merchant API Market: Type Analysis
3.4.1 Global Merchant API Market by Type: An Overview
3.4.2 Global Innovative Merchant API Market by Value
3.4.3 Global Generic Merchant API Market by Value
3.5 Global Merchant API Market: Type of Synthesis Analysis
3.5.1 Global Merchant API Market by Type of Synthesis: An Overview
3.5.2 Global Synthetic Merchant API Market by Value
3.5.3 Global Biotech Merchant API Market by Value
4. Regional Market Analysis
4.1 North America Merchant API Market: An Analysis
4.1.1 North America Merchant API Market: An Overview
4.1.2 North America Merchant API Market by Value
4.1.3 North America Merchant API Market by Region (The US, Canada, and Mexico)
4.1.4 The US Merchant API Market by Value
4.1.5 Canada Merchant API Market by Value
4.1.6 Mexico Merchant API Market by Value
4.2 Asia Pacific Merchant API Market: An Analysis
4.2.1 Asia Pacific Merchant API Market: An Overview
4.2.2 Asia Pacific Merchant API Market by Value
4.2.3 Asia Pacific Merchant API Market by Region (China, India, and Rest of the Asia Pacific)
4.2.4 China Merchant API Market by Value
4.2.5 India Merchant API Market by Value
4.2.6 Rest of Asia Pacific Merchant API Market by Value
4.3 Europe Merchant API Market: An Analysis
4.3.1 Europe Merchant API Market: An Overview
4.3.2 Europe Merchant API Market by Value
4.3.3 Europe Merchant API Market by Region (Germany, The UK, France, Italy, Spain, and Rest of the Europe)
4.3.4 Germany Merchant API Market by Value
4.3.5 The UK Merchant API Market by Value
4.3.6 France Merchant API Market by Value
4.3.7 Italy Merchant API Market by Value
4.3.8 Spain Merchant API Market by Value
4.3.9 Rest of Europe Merchant API Market by Value
4.4 Rest of World Merchant API Market: An Analysis
4.4.1 Rest of World Merchant API Market: An Overview
4.4.2 Rest of World Merchant API Market by Value
5. Impact of COVID-19
5.1 Impact of COVID-19 on Global Merchant API Market
5.2 Post COVID-19 Impact on Global Merchant API Market
6. Market Dynamics
6.1 Growth Drivers
6.1.1 Increasing Incidence of Diabetes
6.1.2 Aging Population
6.1.3 Increasing Healthcare Expenditure
6.1.4 Increasing Research and Development Spending
6.1.5 Growing Pharmaceutical Industry
6.1.6 Growing Pharma Outsourcing Trend
6.2 Challenges
6.2.1 Strict Laws and Regulations
6.2.2 Lack of Transparency and Loss of Control
6.3 Market Trends
6.3.1 Growing Use of Artificial Intelligence
6.3.2 New Drug Approvals
6.3.3 Increasing Patent Expiry
6.3.4 Growth of the High-potency Active Pharmaceutical Ingredients (HPAPI)
7. Competitive Landscape
7.1 Global Merchant API Players by Market Share
7.2 Global Merchant API CDMO Players by Market Share
7.3 Global Peptide Merchant API CDMO Players by Market Share
7.4 Global Oligos Merchant API CDMO Players by Market Share
8. Company Profiles
8.1 Pfizer Inc. (Pfizer CenterOne)
8.1.1 Business Overview
8.1.2 Operating Segments
8.1.3 Business Strategies
8.2 Bachem Holding AG
8.2.1 Business Overview
8.2.2 Net Sales by Product Categories
8.2.3 Business Strategies
8.3 Thermo Fisher Scientific Inc.
8.3.1 Business Overview
8.3.2 Operating Segments
8.3.3 Business Strategy
8.4 Teva Pharmaceutical Industries Ltd. (Teva API)
8.4.1 Business Overview
8.4.2 Operating Segments
8.4.3 Business Strategies
8.5 Sanofi (EuroAPI)
8.5.1 Business Overview
8.5.2 Operating Segments
8.5.3 Business Strategies
8.6 Siegfried Holding AG
8.6.1 Business Overview
8.6.2 Net Sales by Product Group
8.6.3 Business Strategies
8.7 Lonza Group AG
8.7.1 Business Overview
8.7.2 Operating Segments
8.7.3 Business Strategy
8.8 PolyPeptide Group AG
8.8.1 Business Overview
8.8.2 Operating Segments
8.8.3 Business Strategies
8.9 Divi's Laboratories Limited
8.9.1 Business Overview
8.9.2 Revenue by Region
8.10 Centrient Pharmaceuticals
8.10.1 Business Overview
8.10.2 Business Strategies
8.11 Cambrex
8.11.1 Business Overview
8.11.2 Business Strategy
8.12 Fabbrica Italiana Sintetici
8.12.1 Business Overview
List of Figures
Figure 1: Pharma Value Chain
Figure 2: Advantages and Disadvantages of Merchant API
Figure 3: Merchant API Segmentation
Figure 4: Global Merchant API Market by Value; 2017-2021 (US$ Billion)
Figure 5: Global Merchant API Market by Value; 2022-2027 (US$ Billion)
Figure 6: Global Merchant API Market by Molecular Type; 2021 (Percentage, %)
Figure 7: Global Merchant API Market by Segment; 2021 (Percentage, %)
Figure 8: Global Merchant API Market by Type; 2021 (Percentage, %)
Figure 9: Global Merchant API Market by Type of Synthesis; 2021 (Percentage, %)
Figure 10: Global Merchant API Market by Region; 2021 (Percentage, %)
Figure 11: Global Small Molecules Merchant API Market by Value; 2017-2021 (US$ Billion)
Figure 12: Global Small Molecules Merchant API Market by Value; 2022-2027 (US$ Billion)
Figure 13: Global Large Molecules Merchant API Market by Value; 2017-2021 (US$ Billion)
Figure 14: Global Large Molecules Merchant API Market by Value; 2022-2027 (US$ Billion)
Figure 15: Global Merchant API CDMO Market by Value; 2017-2021 (US$ Billion)
Figure 16: Global Merchant API CDMO Market by Value; 2022-2027 (US$ Billion)
Figure 17: Global Merchant API CDMO Market by Molecular Type; 2021 (Percentage, %)
Figure 18: Global Merchant API CDMO Molecular Type Market by Value; 2017-2021 (US$ Billion)
Figure 19: Global Merchant API CDMO Molecular Type Market by Value; 2022-2027 (US$ Billion)
Figure 20: Global Merchant API CDMO Market by End-User; 2021 (Percentage, %)
Figure 21: Global Merchant API CDMO End-User Market by Value; 2017-2021 (US$ Billion)
Figure 22: Global Merchant API CDMO End-User Market by Value; 2022-2027 (US$ Billion)
Figure 23: Global Merchant API Solutions Market by Value; 2017-2021 (US$ Billion)
Figure 24: Global Merchant API Solutions Market by Value; 2022-2027 (US$ Billion)
Figure 25: Global Innovative Merchant API Market by Value; 2017-2021 (US$ Billion)
Figure 26: Global Innovative Merchant API Market by Value; 2022-2027 (US$ Billion)
Figure 27: Global Generic Merchant API Market by Value; 2017-2021 (US$ Billion)
Figure 28: Global Generic Merchant API Market by Value; 2022-2027 (US$ Billion)
Figure 29: Global Synthetic Merchant API Market by Value; 2017-2021 (US$ Billion)
Figure 30: Global Synthetic Merchant API Market by Value; 2022-2027 (US$ Billion)
Figure 31: Global Biotech Merchant API Market by Value; 2017-2021 (US$ Billion)
Figure 32: Global Biotech Merchant API Market by Value; 2022-2027 (US$ Billion)
Figure 33: North America Merchant API Market by Value; 2017-2021 (US$ Billion)
Figure 34: North America Merchant API Market by Value; 2022-2027 (US$ Billion)
Figure 35: North America Merchant API Market by Region; 2021 (Percentage, %)
Figure 36: The US Merchant API Market by Value; 2017-2021 (US$ Billion)
Figure 37: The US Merchant API Market by Value; 2022-2027 (US$ Billion)
Figure 38: Canada Merchant API Market by Value; 2017-2021 (US$ Billion)
Figure 39: Canada Merchant API Market by Value; 2022-2027 (US$ Billion)
Figure 40: Mexico Merchant API Market by Value; 2017-2021 (US$ Million)
Figure 41: Mexico Merchant API Market by Value; 2022-2027 (US$ Billion)
Figure 42: Asia Pacific Merchant API Market by Value; 2017-2021 (US$ Billion)
Figure 43: Asia Pacific Merchant API Market by Value; 2022-2027 (US$ Billion)
Figure 44: Asia Pacific Merchant API Market by Region; 2021 (Percentage, %)
Figure 45: China Merchant API Market by Value; 2017-2021 (US$ Billion)
Figure 46: China Merchant API Market by Value; 2022-2027 (US$ Billion)
Figure 47: India Merchant API Market by Value; 2017-2021 (US$ Billion)
Figure 48: India Merchant API Market by Value; 2022-2027 (US$ Billion)
Figure 49: Rest of Asia Pacific Merchant API Market by Value; 2017-2021 (US$ Billion)
Figure 50: Rest of Asia Pacific Merchant API Market by Value; 2022-2027 (US$ Billion)
Figure 51: Europe Merchant API Market by Value; 2017-2021 (US$ Billion)
Figure 52: Europe Merchant API Market by Value; 2022-2027 (US$ Billion)
Figure 53: Europe Merchant API Market by Region; 2021 (Percentage, %)
Figure 54: Germany Merchant API Market by Value; 2017-2021 (US$ Billion)
Figure 55: Germany Merchant API Market by Value; 2022-2027 (US$ Billion)
Figure 56: The UK Merchant API Market by Value; 2017-2021 (US$ Billion)
Figure 57: The UK Merchant API Market by Value; 2022-2027 (US$ Billion)
Figure 58: France Merchant API Market by Value; 2017-2021 (US$ Billion)
Figure 59: France Merchant API Market by Value; 2022-2027 (US$ Billion)
Figure 60: Italy Merchant API Market by Value; 2017-2021 (US$ Billion)
Figure 61: Italy Merchant API Market by Value; 2022-2027 (US$ Billion)
Figure 62: Spain Merchant API Market by Value; 2017-2021 (US$ Billion)
Figure 63: Spain Merchant API Market by Value; 2022-2027 (US$ Billion)
Figure 64: Rest of Europe Merchant API Market by Value; 2017-2021 (US$ Billion)
Figure 65: Rest of Europe Merchant API Market by Value; 2022-2027 (US$ Billion)
Figure 66: Rest of World Merchant API Market by Value; 2017-2021 (US$ Billion)
Figure 67: Rest of World Merchant API Market by Value; 2022-2027 (US$ Billion)
Figure 68: Global Number of Diabetic Population; 2000-2045 (Million)
Figure 69: Global Population Aged 65 Years Or Over; 2022-2050 (Percentage, %)
Figure 70: Global Health Spending Per Capita; 2017-2021 (US$ Thousand)
Figure 71: Global Spending on Pharmaceutical Research And Development; 2019-2028 (US$ Billion)
Figure 72: Global Pharmaceutical Market Revenue; 2013-2021 (US$ Trillion)
Figure 73: Global Artificial Intelligence Market Size; 2021-2025 (US$ Billion)
Figure 74: Global Merchant API Players by Market Share; 2021 (Percentage, %)
Figure 75: Global Merchant API CDMO Players by Market Share; 2021 (Percentage, %)
Figure 76: Global Peptide Merchant API CDMO Players by Market Share; 2021 (Percentage, %)
Figure 77: Global Oligos Merchant API CDMO Players by Market Share; 2021 (Percentage, %)
Figure 78: Pfizer Inc. Revenues by Operating Segments; 2021 (Percentage, %)
Figure 79: Bachem Holding AG Net Sales by Product Categories; 2021 (Percentage, %)
Figure 80: Thermo Fisher Scientific Inc. Revenues by Segments; 2021 (Percentage, %)
Figure 81: Teva Pharmaceutical Industries Ltd. Revenues by Segments; 2021 (Percentage, %)
Figure 82: Sanofi Net Sales by Segments; 2021 (Percentage, %)
Figure 83: Siegfried Holding AG Net Sales by Product Group; 2021 (Percentage, %)
Figure 84: Lonza Group AG Sales by Segments; 2021 (Percentage, %)
Figure 85: PolyPeptide Group AG Revenue by Segment; 2021 (Percentage, %)
Figure 86: Divi's Laboratories Limited Revenue by Region; 2022 (Percentage, %)
Table 1: Novel Drug Approvals for 2021
―――――
